ECONOMIC EVALUATION OF IBRUTINIB FOR THE TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY MANTLE-CELL LYMPHOMA IN MEXICO
Abstract
Authors
F. Carlos M. Herrera A. Salazar A. Aguirre L. Gonzalez-Michaca
F. Carlos M. Herrera A. Salazar A. Aguirre L. Gonzalez-Michaca
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now